SCHEMBL13626470

SCHEMBL13626470

C=C1C(c2ccc(Nc3nc(Br)cn(C)c3=O)cc2)N(C)CCN1C

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1203837 0.89 BTK (0.51) BTK
SCHEMBL1205490 0.89 BTK (0.51) BTK
SCHEMBL1204149 0.89 BTK (0.51) BTK
SCHEMBL161076 0.83 BTK (0.49) BTK
SCHEMBL19545087 0.83 BTK (0.49) BTK
SCHEMBL1204826 0.82 BTK (0.42) BTK
SCHEMBL160223 0.79 BTK (0.46) BTK
SCHEMBL10256464 0.77 BTK (0.46) BTK
SCHEMBL10256242 0.77 BTK (0.39) BTK
SCHEMBL12177877 0.75 BTK (0.36) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137596-A1 SUBSTITUTED AMIDES, METHOD OF MAKING, AND USE AS BTK INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed
WO-2009039397-A2 SUBSTITUTED AMIDES, METHODS OF MAKING, USE THEREOF FOR THE TREATMENT OF DISEASES SUCH AS CANCER CGI PHARMACEUTICALS, INC. (US) 2009-03-26 WO disclosed